| Stage | NP | % of rev | ARXS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $60M | 100.00% | $564M | 100.00% | ARXS ×9.47 |
| Gross profit | $60M | 100.00% | $306M | 54.27% | NP +45.7pp |
| Operating income | $28M | 46.95% | $133M | 23.66% | NP +23.3pp |
| Pre-tax income | $25M | 41.49% | $120M | 21.23% | NP +20.3pp |
| Net income | $17M | 28.97% | $84M | 14.84% | NP +14.1pp |
| Stage | NP | ARXS | Gap · A − B |
|---|---|---|---|
| Revenue | $60M100.00% | $564M100.00% | ARXS ×9.47 |
| Gross profit | 100.00%$60M | 54.27%$306M | NP +45.7pp |
| Operating income | 46.95%$28M | 23.66%$133M | NP +23.3pp |
| Pre-tax income | 41.49%$25M | 21.23%$120M | NP +20.3pp |
| Net income | 28.97%$17M | 14.84%$84M | NP +14.1pp |
No disclosed counterparties: ARXS.
None